Back to top
more

GoodRx (GDRX)

(Delayed Data from NSDQ)

$8.37 USD

8.37
936,781

+0.06 (0.72%)

Updated Jul 16, 2024 04:00 PM ET

After-Market: $8.37 0.00 (0.00%) 5:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 41% (102 out of 250)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for GDRX

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for GoodRx Holdings, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 672 757 941 972 26
Receivables 144 117 118 69 48
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 57 45 30 46 12
Total Current Assets 873 920 1,089 1,086 87
Net Property & Equipment 111 90 67 43 7
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 65 0 0 13 2
Intangibles 472 532 418 298 257
Deposits & Other Assets 38 27 6 2 1
Total Assets 1,589 1,605 1,608 1,470 387
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 36 18 18 10 8
Current Portion Long-Term Debt 9 7 7 7 7
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 71 48 51 38 16
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 123 76 81 60 33
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 648 652 656 660 664
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 8 8 5 6 3
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 827 790 776 759 737
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 737
Common Stock (Par) 0 0 0 0 0
Capital Surplus 2,219 2,263 2,247 2,102 9
Retained Earnings -1,457 -1,449 -1,416 -1,390 -1,097
Other Equity 0 0 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 762 815 832 711 -351
Total Liabilities & Shareholder's Equity 1,589 1,605 1,608 1,470 387
Total Common Equity 762 815 832 711 -1,088
Shares Outstanding 394.00 397.00 400.50 391.60 NA
Book Value Per Share 1.93 2.05 2.08 1.82 0.01

Fiscal Year End for GoodRx Holdings, Inc falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents -99,999 533 672 795 762
Receivables NA 145 144 121 123
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 55 57 53 34
Total Current Assets NA 733 873 969 919
Net Property & Equipment NA 119 111 109 111
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 65 65 58 63
Intangibles NA 469 472 502 521
Deposits & Other Assets NA 37 38 39 44
Total Assets NA 1,454 1,589 1,708 1,692
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 34 36 33 7
Current Portion Long-Term Debt NA 7 9 7 7
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 71 71 75 66
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 117 123 118 83
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 647 648 649 650
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 8 8 10
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 823 827 827 797
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 2,089 2,219 2,313 2,288
Retained Earnings NA -1,458 -1,457 -1,432 -1,393
Other Equity NA 0 0 0 0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 631 762 881 895
Total Liabilities & Shareholder's Equity NA 1,454 1,589 1,708 1,692
Total Common Equity 0 631 762 881 895
Shares Outstanding 375.20 395.00 394.00 398.30 396.60
Book Value Per Share 0.00 1.60 1.93 2.21 2.26